A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis.

In patients with atherosclerotic carotid lesions, high levels of C1M predicted cardiovascular events, cardiovascular mortality and all-cause mortality. These findings emphasize the importance of remodelling mechanisms in atherosclerosis that are now becoming more and more explored.